Intrexon to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced Lt. General (Ret.) Thomas P. Bostick, PhD, PE, Dist.M. ASCE, NAE, Intrexon's Chief Operating Officer, and Thomas E. Shrader, PhD, CFA, Vice President, Communications and Strategy,...

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced Lt. General (Ret.) Thomas P. Bostick, PhD, PE, Dist.M. ASCE, NAE, Intrexon's Chief Operating Officer, and Thomas E. Shrader, PhD, CFA, Vice President, Communications and Strategy, will participate in a fireside chat session at the Bank of America Merrill Lynch 2018 Healthcare Conference at Encore at the Wynn, Las Vegas, Nevada on Tuesday, May 15th, at 5:00 p.m. Pacific Time

About Intrexon Corporation:
Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet.  Intrexon's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn.

Trademarks
Intrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners.

10778

 

Source: investors.dna.com